与帕金森氏症相关的FBXO7基因的新突变损害了线粒体和蛋白质体的功能
Elisa Navarro1,2,3, Noemí Esteras1,2,4
1Department of Biochemistry and Molecular Biology, School of Medicine, Neurochemistry Research Institute, Complutense University of Madrid, Spain.
The FEBS journal
|May 6, 2024
概括
FBXO7基因L250P的新突变破坏了儿童帕金森病患者的蛋白质体功能和线粒体健康. 这一发现强调了蛋白质降解和线粒体动态在PD中的关键作用.
科学领域:
- 遗传学和分子生物学
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病 (PD) 与遗传因素有关,像FBXO7这样的基因突变约占病例的10%.
- FBXO7编码了Skp1-Cullin-F-box (SCF) 泛素E3结合酶复合物的关键组成部分,这对于向蛋白质进行蛋白质酶体降解至关重要.
- 功能失调的蛋白质降解和线粒体路径越来越被认为是PD病变发生的核心.
研究的目的:
- 在儿童帕金森病患者中发现的FBXO7基因 (L250P) 新型突变的特征.
- 调查L250P突变对Fbxo7蛋白相互作用,蛋白质体活性和基质无化功能的后果.
- 探索L250P突变对线粒体功能和线粒体衰变的影响.
主要方法:
- 基因测序以确定患者中的FBXO7 L250P突变.
- 生物化学试验评估Fbxo7与蛋白酶调节器PI31.1.的相互作用.
- 对Fbxo7位的蛋白质体活性和无处不在的分析.
- 线粒体功能测定和线粒体的评估.
主要成果:
- 在一个儿科PD患者中发现了L250P突变.
- 这种突变取消了Fbxo7和蛋白酶体抑制剂31kD (PI31) 之间的相互作用.
- L250P突变损害了特定Fbxo7标的蛋白质体降解,并破坏了线粒体功能和线粒体.
结论:
- 新的FBXO7 L250P突变通过破坏蛋白质体降解途径,为PD做出贡献.
- 线粒体功能受损和线粒体是这种突变的重要后果,强调了它们在PD中的作用.
- 这项研究强调了在帕金森病的发展中遗传突变,蛋白质降解机制和线粒体健康之间的联系.
相关概念视频
01:15Parkinson's Disease: Overview
533
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
533
01:48ATP Synthase: Mechanism
14.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.5K
01:13The Proteasome
830
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
830
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:19Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
01:39Mutations
82.0K
Overview
82.0K